KRYS logo

KRYS
Krystal Biotech Inc

1,736
Mkt Cap
$7.29B
Volume
119,013.00
52W High
$255.00
52W Low
$122.80
PE Ratio
37.69
KRYS Fundamentals
Price
$251.29
Prev Close
$253.36
Open
$253.67
50D MA
$212.63
Beta
0.94
Avg. Volume
311,934.11
EPS (Annual)
$3.00
P/B
6.40
Rev/Employee
$1.06M
Loading...
Loading...
News
all
press releases
Krystal Biotech (NASDAQ:KRYS) Hits New 52-Week High - Should You Buy?
Krystal Biotech (NASDAQ:KRYS) Hits New 12-Month High - Should You Buy...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Krystal Biotech, Inc. (NASDAQ:KRYS) Given Average Recommendation of "Moderate Buy" by Brokerages
Krystal Biotech, Inc. (NASDAQ:KRYS - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the eight analysts that are currently covering the firm, Marketbeat reports. Two...
MarketBeat·9d ago
News Placeholder
Krystal Biotech, Inc. $KRYS is Redmile Group LLC's 2nd Largest Position
Redmile Group LLC decreased its position in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 10.1% during the second quarter, according to the company in its most recent disclosure with the SEC...
MarketBeat·14d ago
News Placeholder
First Trust Advisors LP Buys 189,245 Shares of Krystal Biotech, Inc. $KRYS
First Trust Advisors LP lifted its stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 571.3% in the second quarter, according to the company in its most recent filing with the...
MarketBeat·15d ago
News Placeholder
Krystal Biotech (NASDAQ:KRYS) Reaches New 12-Month High - Still a Buy?
Krystal Biotech (NASDAQ:KRYS) Reaches New 12-Month High - What's Next...
MarketBeat·15d ago
News Placeholder
Hood River Capital Management LLC Purchases 8,379 Shares of Krystal Biotech, Inc. $KRYS
Hood River Capital Management LLC grew its holdings in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 1.6% during the second quarter, according to the company in its most recent Form 13F filing...
MarketBeat·18d ago
News Placeholder
282,706 Shares in Krystal Biotech, Inc. $KRYS Bought by Norges Bank
Norges Bank acquired a new stake in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The...
MarketBeat·18d ago
News Placeholder
JPMorgan Chase & Co. Sells 9,621 Shares of Krystal Biotech, Inc. $KRYS
JPMorgan Chase & Co. lowered its position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 9.5% in the 2nd quarter, according to the company in its most recent Form 13F filing with...
MarketBeat·18d ago
News Placeholder
Suma Krishnan Sells 25,000 Shares of Krystal Biotech (NASDAQ:KRYS) Stock
Krystal Biotech, Inc. (NASDAQ:KRYS - Get Free Report) insider Suma Krishnan sold 25,000 shares of the stock in a transaction that occurred on Thursday, December 4th. The shares were sold at an...
MarketBeat·19d ago
News Placeholder
Krystal Biotech (NASDAQ:KRYS) Insider Sells $5,504,000.00 in Stock
Krystal Biotech, Inc. (NASDAQ:KRYS - Get Free Report) insider Suma Krishnan sold 25,000 shares of the business's stock in a transaction dated Thursday, December 4th. The shares were sold at an...
MarketBeat·19d ago
<
1
2
...
>

Latest KRYS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.